Preliminary results of a phase 2 clinical trial of Genz-112638 in patients with type I Gaucher disease

被引：0
|
作者：
Lukina, E. [1 ]
Watman, N. [2 ]
Arreguin, E. A.
Banikazemi, M. [3 ]
Iastrebner, M. [4 ]
Rosenbaum, H. [5 ]
Zimran, A. [6 ]
O'Brien, F.
Smith, S. E.
Puga, A. C.
Peterschmitt, J.
机构：
[1] Russian Acad Med Sci, Hematol Res Ctr, Moscow, Russia
[2] Hosp Ramos Mejia, Buenos Aires, DF, Argentina
[3] NYU, New York, NY USA
[4] Inst Argentino Diagnost & Tratamiento, Buenos Aires, DF, Argentina
[5] Ramban Med Ctr, Haifa, Israel
[6] Shaare Zedek Med Ctr, Jerusalem, Israel
来源：
JOURNAL OF INHERITED METABOLIC DISEASE | 2008年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
450P
引用
收藏
页码：114 / 114
页数：1
相关论文
共 50 条
  • [41] Preliminary results of a phase I/II clinical trial using in situ photoimmunotherapy combined with imiquimod for metastatic melanoma patients
    Li, Xiaosong
    Naylor, Mark F.
    Nordquist, Robert E.
    Teague, T. Kent
    Howard, C. Anthony
    Murray, Cynthia
    Chen, Wei R.
    BIOPHOTONICS AND IMMUNE RESPONSES V, 2010, 7565
  • [42] Venglustat in adult Gaucher disease type 3: Preliminary safety, pharmacology, and exploratory efficacy from a phase 2 trial in combination with imiglucerase (LEAP)
    Schiffmann, Raphael
    Mengel, Eugen
    Crawford, Nigel
    Gaemers, Sebastiaan
    Hughes, Derralynn
    Jovanovic, Ana
    Minini, Pascal
    Sharma, Jyoti
    Fischer, Tanya
    MOLECULAR GENETICS AND METABOLISM, 2019, 126 (02) : S131 - S131
  • [43] Effect of Oral Eliglustat on Splenomegaly in Patients With Gaucher Disease Type 1 The ENGAGE Randomized Clinical Trial
    Mistry, Pramod K.
    Lukina, Elena
    Ben Turkia, Hadhami
    Amato, Dominick
    Baris, Hagit
    Dasouki, Majed
    Ghosn, Marwan
    Mehta, Atul
    Packman, Seymour
    Pastores, Gregory
    Petakov, Milan
    Assouline, Sarit
    Balwani, Manisha
    Danda, Sumita
    Hadjiev, Evgueniy
    Ortega, Andres
    Shankar, Suma
    Helena Solano, Maria
    Ross, Leorah
    Angell, Jennifer
    Peterschmitt, M. Judith
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 313 (07): : 695 - 706
  • [44] Alglucerase therapy for Gaucher's disease. Preliminary results in Spanish patients
    Giraldo, P
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 708 - 708
  • [45] A detailed program model for a community aphasia group: Preliminary results for a phase I clinical trial
    Attard, M.
    Rose, M.
    Togher, L.
    INTERNATIONAL JOURNAL OF STROKE, 2016, 11 : 21 - 21
  • [46] Immucell reports positive preliminary results from DiffGAM phase I/II clinical trial
    不详
    DRUG NEWS & PERSPECTIVES, 2000, 13 (02) : 113 - 113
  • [47] Gene therapy for retinoblastoma: Preliminary results of a phase I trial
    Chintagumpala, MM
    Chevez-Barrios, P
    Boniuk, M
    Hurwitz, MY
    Hurwitz, RL
    PEDIATRIC RESEARCH, 2003, 53 (04) : 271A - 271A
  • [48] Clinical characteristics of Gaucher's disease in Spain. Preliminary results of a national inquiry
    Giraldo, P
    PerezCalvo, JI
    Giralt, M
    Pocovi, M
    MEDICINA CLINICA, 1997, 109 (16): : 619 - 622
  • [49] Subtle neuropsychological abnormalities in patients with type I Gaucher disease.
    Elstein, D
    Guedalia, J
    Rosenberg, P
    Antebi, V
    Arnon, Y
    Zimran, A
    AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 73 (05) : 449 - 449
  • [50] Treat type I Gaucher disease with miglustat - Experience with two patients
    Yang, Sandra
    Tifft, Cynthia
    MOLECULAR GENETICS AND METABOLISM, 2007, 92 (04) : S22 - S22
12345